Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Multiple Sclerosis market to reach more than $18bn by 2018
Multiple Sclerosis market to reach more than $18bn by 2018
Multiple Sclerosis market to reach more than $18bn by 2018
Submitted by
admin
on August 20, 2013 - 12:13pm
Source:
Datamonitor Healthcare
News Tags:
MS
multiple sclerosis
Biogen Idec
Tecfidera
Headline:
Multiple Sclerosis market to reach more than $18bn by 2018
Do Not Allow Advertisers to Use My Personal information
